NovaBridge Biosciences: cost_of_revenue
| Value | {"unit": "CNY", "value": 0, "concept": "us-gaap:CostOfRevenue"} |
|---|---|
| Period | 2020-01-01 – 2020-12-31 |
| Status | current |
| Entity | NovaBridge Biosciences |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:00:43.919806+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/68d28025-df35-41f8-99dc-ab683acd6f58
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-22-133550Retrieved: 2026-08-19T18:00:43.919806+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001778016/cost-of-revenue/2020-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/68d28025-df35-41f8-99dc-ab683acd6f58
History
- no predecessors — first report